You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 7, 2025

Drug Price Trends for NDC 10702-0040


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 10702-0040

Drug Name NDC Price/Unit ($) Unit Date
BENZPHETAMINE HCL 50 MG TABLET 10702-0040-01 11.41640 EACH 2025-01-22
BENZPHETAMINE HCL 50 MG TABLET 10702-0040-03 11.41640 EACH 2025-01-22
BENZPHETAMINE HCL 50 MG TABLET 10702-0040-50 11.41640 EACH 2025-01-22
BENZPHETAMINE HCL 50 MG TABLET 10702-0040-01 11.41640 EACH 2024-12-18
BENZPHETAMINE HCL 50 MG TABLET 10702-0040-03 11.41640 EACH 2024-12-18
BENZPHETAMINE HCL 50 MG TABLET 10702-0040-50 11.41640 EACH 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 10702-0040

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC: 10702-0040

Understanding the NDC Code

The NDC code 10702-0040 is a unique identifier for a specific drug product. This code is part of the National Drug Code (NDC) system, which is used to identify prescription drugs, over-the-counter (OTC) drugs, and insulin products in the United States. The NDC code is a 10-digit, three-segment number that identifies the labeler, product, and package size of the drug[1].

Drug Product Identification

For the NDC code 10702-0040, here is a breakdown of what each segment represents:

  • Labeler Code: The first segment (10702) is assigned by the FDA and identifies the firm that manufactures, repacks, or distributes the drug.
  • Product Code: The second segment identifies the specific strength, dosage form, and formulation of the drug.
  • Package Code: The third segment identifies the package size and type.

Market Context

To analyze the market and project prices for this drug, it is crucial to understand the broader pharmaceutical market trends.

Prescription Drug Market Trends

The prescription drug market is influenced by several factors, including regulatory oversight, technological advancements, and consumer behavior. Here are some key trends:

  • Price Transparency: There is a growing push for price transparency in the pharmaceutical industry. Programs like Oregon's Prescription Drug Price Transparency Act require manufacturers to report price increases and other cost-related information, which helps in understanding the factors influencing drug prices[2].
  • Price Increases: The percentage of drugs with price increases has been decreasing, but the average percent of increase remains higher than the consumer price index (CPI-U). For example, in 2022, the average percent increase was 10.79%, which is higher than the CPI-U of 6.5%[4].

Biopharma and Biotech Industry Growth

The biopharma and biotech industries are experiencing rapid growth, driven by technological advancements and evolving regulatory frameworks. The market size for biopharmaceuticals is projected to grow at a compound annual growth rate (CAGR) of 7.56% between 2024 and 2029, while the biotech market is expected to grow at a CAGR of 9.4% between 2021 and 2027[3].

Price Projections for NDC: 10702-0040

Given the trends and factors influencing the pharmaceutical market, here are some considerations for price projections:

Historical Price Data

To project future prices, it is essential to analyze historical price data for the drug. For instance, if the drug has experienced price increases in the past, understanding the magnitude and frequency of these increases can help in predicting future trends.

Regulatory and Market Factors

  • Regulatory Oversight: Changes in regulatory policies, such as those related to price transparency and affordability boards, can impact drug prices. For example, the creation of prescription drug affordability boards in some states could lead to upper payment limits for certain drugs, potentially affecting prices[2].
  • Market Competition: The level of competition in the market, including the presence of generic alternatives, can also influence prices. Generic drugs often see significant price decreases, which can impact the pricing strategy for brand-name drugs[4].

Consumer and Payer Dynamics

  • Consumer Behavior: Consumer behavior, such as adherence to medication due to cost concerns, can affect demand and subsequently prices. A significant portion of Americans report not taking their medications as prescribed due to cost, which can impact the overall market dynamics[2].
  • Payer Negotiations: Rebates and discounts negotiated by pharmacy benefit managers (PBMs) and other payers can also influence the net cost of drugs to consumers and payers. For brand drugs, rebates can significantly offset costs, resulting in net costs below the wholesale acquisition cost (WAC)[4].

Example: Oxycodone Hydrochloride Pricing

To illustrate how these factors can influence pricing, consider Oxycodone Hydrochloride, another product from the same labeler (KVK-TECH, INC). The pricing for Oxycodone Hydrochloride can be affected by similar market and regulatory factors. For instance, if there is a significant increase in the price of Oxycodone Hydrochloride due to supply chain issues or regulatory changes, it could set a precedent for other drugs from the same labeler[5].

Key Takeaways

  • Regulatory Transparency: Increased regulatory transparency and reporting requirements can help in understanding and predicting price trends.
  • Market Competition: The presence of generic alternatives and competitive market dynamics can significantly impact the pricing of brand-name drugs.
  • Consumer and Payer Behavior: Consumer adherence to medication and payer negotiations play crucial roles in determining the net cost of drugs.
  • Technological and Regulatory Advancements: The biopharma and biotech industries' rapid growth and evolving regulatory frameworks will continue to shape the pharmaceutical market.

FAQs

  1. What is the NDC code, and how is it structured?

    • The NDC code is a 10-digit, three-segment number that identifies the labeler, product, and package size of a drug. The first segment is the labeler code, the second is the product code, and the third is the package code[1].
  2. Why are some drug products not included in the NDC Directory?

    • Drug products may not be included if they are not prescription drugs, OTC drugs, or insulin products, or if the firm has not complied with listing obligations or has notified the FDA that the product is no longer being marketed[1].
  3. How do regulatory policies impact drug prices?

    • Regulatory policies such as price transparency acts and the creation of prescription drug affordability boards can influence drug prices by requiring manufacturers to report price increases and potentially setting upper payment limits[2].
  4. What role do pharmacy benefit managers (PBMs) play in drug pricing?

    • PBMs negotiate rebates and discounts with manufacturers, which can significantly offset the costs to payers and result in net costs below the wholesale acquisition cost (WAC)[4].
  5. How does consumer behavior affect drug prices?

    • Consumer behavior, such as not taking medications as prescribed due to cost concerns, can impact demand and subsequently influence pricing strategies and market dynamics[2].

Sources

  1. FDA - National Drug Code Database Background Information
  2. Oregon’s Prescription Drug Price Transparency Program - Annual Report 2022
  3. TFS CRO - 5 Predictions for the Biopharma and Biotech Industries in 2025
  4. Maine Health Data Organization - Rx Transparency Report 2024
  5. PharmaCompass - NDC Code 10702-009-50

More… ↓

⤷  Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.